So yeah, it seems like the field is a bit discombobulated.
From one paper:
Conclusion: Statins do not reduce or enhance CAC as measured by Agatston score in asymptomatic populations at high risk of cardiovascular diseases, but seem to slow down CAC progression.
From another:
Conclusions: Despite a greater CAC increase with high dose and long-term statin therapy, events did not occur more frequently in statin treated patients. This suggests that CAC growth under treatment with statins represents plaque repair rather than continuing plaque expansion.
This conflicting inherent assumption that raising CAC scores is a good thing - even as calcification is generally seen as a bad thing - seems at first to be counter-intuitive. But perhaps the mystery might be solved by incorporating the density of calcified plaque as other researchers have done.
Personally, Iâm still at a loss to see how taking a statin is helpful to oneâs overall good health. Even if it were to promote calcification of arteries, pitched here as a good thing, statins typically reduce all cholesterol - including HDL.
Our bodies need cholesterol. Our brains are made largely of cholesterol. Reducing it has been shown repeatedly to be associated with increased overall mortality risk.